Expert opinion
Video: Perspective on Personalized Nutrition from Lucy Jones, RD
24 October 2018
Internationally-recognized registered dietitian, Lucy Jones, provides her perspective on the fast-growing segment of personalized nutrition.
22 July 2009
Higher serum levels of the main circulating form of vitamin D, 25-hydroxyvitamin D (25(OH)D), are associated with substantially lower incidence rates of colon, breast, ovarian, renal, pancreatic, aggressive prostate and other cancers, as suggested by a new publication.
The authors combined epidemiological findings with newly discovered mechanisms suggesting a new ‘seven phase’ model of cancer development: disjunction, initiation, natural selection, overgrowth, metastasis, involution, and transition. Vitamin D metabolites are thought to prevent disjunction of cells and are beneficial in other phases.
As suggested by the researchers, an increase of the minimum year-round serum vitamin D level from 40–60 ng/mL (100–150 nmol/L) would prevent approximately 58,000 new cases of breast cancer and 49,000 new cases of colorectal cancer each year, and three-quarters of deaths from these diseases in the United States and Canada, based on observational studies combined with a randomized trial.
“The time has arrived for nationally coordinated action to substantially increase intake of vitamin D and calcium”, the authors added. (1)
24 October 2018
Internationally-recognized registered dietitian, Lucy Jones, provides her perspective on the fast-growing segment of personalized nutrition.
23 July 2012
According to a new systematic review, milk and cereal products fortified with iron and a combination of other micronutrients, such as vitamin A and zinc, are more likely to help reduce iron-deficiency anemia in children than foods fortified with iron alone.
11 January 2016
A new paper has re-examined data from the large Australian DOMInO (DHA to Optimize Mother and Infant Outcome) study which looked at the effects of an intervention with a supplement containing the marine omega-3 fatty acid docosahexaenoic acid (DHA) on the birth outcomes of 2,399 pregnant women. The intervention enabled cost savings for the hospitals – particularly in terms of shorter hospital stays – equivalent to an average of 92 AUD per singleton pregnancy (equivalent to 60 EUR or 66 USD), which equates on an annual basis to potential annual savings of between 15 to 51 million AUD (10 to 33 million EUR) for the Australian public hospital system.